كندا - الفرنسية - Health Canada

janssen inc - Époétine alpha - solution - 10000unité - Époétine alpha 10000unité - hematopoietic agents

كندا - الفرنسية - Health Canada

janssen inc - Époétine alpha - solution - 4000unité - Époétine alpha 4000unité - hematopoietic agents

كندا - الفرنسية - Health Canada

janssen inc - Époétine alpha - solution - 2000unité - Époétine alpha 2000unité - hematopoietic agents

كندا - الفرنسية - Health Canada

modern veterinary therapeutics llc - moxidectine; imidaclopride - solution - 4mg; 40mg - moxidectine 4mg; imidaclopride 40mg - chats; mammifères (divers)

كندا - الفرنسية - Health Canada

modern veterinary therapeutics llc - moxidectine; imidaclopride - solution - 8mg; 80mg - moxidectine 8mg; imidaclopride 80mg - chats

كندا - الفرنسية - Health Canada

modern veterinary therapeutics llc - moxidectine; imidaclopride - solution - 10mg; 40mg - moxidectine 10mg; imidaclopride 40mg - chiens

كندا - الفرنسية - Health Canada

modern veterinary therapeutics llc - moxidectine; imidaclopride - solution - 25mg; 100mg - moxidectine 25mg; imidaclopride 100mg - chiens

كندا - الفرنسية - Health Canada

modern veterinary therapeutics llc - moxidectine; imidaclopride - solution - 62.5mg; 250mg - moxidectine 62.5mg; imidaclopride 250mg - chiens

كندا - الفرنسية - Health Canada

modern veterinary therapeutics llc - moxidectine; imidaclopride - solution - 100mg; 400mg - moxidectine 100mg; imidaclopride 400mg - chiens

الاتحاد الأوروبي - الفرنسية - EMA (European Medicines Agency)

virbac s.a. - l'interféron oméga recombinant d'origine féline - les immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. chez les chats infectés par le fiv, la mortalité était faible (5%) et n'a pas été influencée par le traitement..